1. Home
  2. ICUI vs WHD Comparison

ICUI vs WHD Comparison

Compare ICUI & WHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • WHD
  • Stock Information
  • Founded
  • ICUI 1984
  • WHD 2011
  • Country
  • ICUI United States
  • WHD United States
  • Employees
  • ICUI N/A
  • WHD N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • WHD Metal Fabrications
  • Sector
  • ICUI Health Care
  • WHD Industrials
  • Exchange
  • ICUI Nasdaq
  • WHD Nasdaq
  • Market Cap
  • ICUI 3.4B
  • WHD 2.8B
  • IPO Year
  • ICUI 1992
  • WHD 2018
  • Fundamental
  • Price
  • ICUI $127.74
  • WHD $45.07
  • Analyst Decision
  • ICUI Strong Buy
  • WHD Hold
  • Analyst Count
  • ICUI 5
  • WHD 6
  • Target Price
  • ICUI $196.75
  • WHD $52.33
  • AVG Volume (30 Days)
  • ICUI 198.1K
  • WHD 617.8K
  • Earning Date
  • ICUI 08-06-2025
  • WHD 07-30-2025
  • Dividend Yield
  • ICUI N/A
  • WHD 1.15%
  • EPS Growth
  • ICUI N/A
  • WHD 11.86
  • EPS
  • ICUI N/A
  • WHD 2.83
  • Revenue
  • ICUI $2,420,093,000.00
  • WHD $1,136,010,000.00
  • Revenue This Year
  • ICUI N/A
  • WHD $1.08
  • Revenue Next Year
  • ICUI N/A
  • WHD $8.32
  • P/E Ratio
  • ICUI N/A
  • WHD $15.98
  • Revenue Growth
  • ICUI 7.22
  • WHD N/A
  • 52 Week Low
  • ICUI $111.97
  • WHD $33.80
  • 52 Week High
  • ICUI $196.26
  • WHD $70.01
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 39.54
  • WHD 55.89
  • Support Level
  • ICUI $125.78
  • WHD $45.53
  • Resistance Level
  • ICUI $133.85
  • WHD $46.94
  • Average True Range (ATR)
  • ICUI 3.34
  • WHD 1.43
  • MACD
  • ICUI -0.32
  • WHD -0.02
  • Stochastic Oscillator
  • ICUI 15.71
  • WHD 64.36

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

Share on Social Networks: